22 May 2020

In the journal Radiology researchers from Radboudumc, Bernhoven Hospital and Jeroen Bosch Hospital described the evaluation of a newly developed artificial intelligence (AI) system, CAD4COVID-XRay, for the detection of COVID-19 characteristics on chest X-ray (CXR). 

The system is developed by Thirona and is available cost-free to any institution upon request.  The system was trained on 24,678 CXR images and tested on a set of 454 images from an independent center (223 patients tested positive for COVID-19, the remaining 231 tested negative).  The CXR images were also examined and scored by 6 radiologists independently.  Analysis was performed by calculation of the receiver operating characteristic curve (ROC).  In the task of identifying COVID-19 positive patients the AI system performed at a level comparable to all six radiologists and had an area under the ROC of 0.81.  The system may be useful as part of a triage process for symptomatic subjects, particularly in low-resource settings where radiological expertise is not available. 
 
Abstract
Background Chest radiography (CXR) may play an important role in triage for COVID-19, particularly in low-resource settings. Purpose To evaluate the performance of an artificial intelligence (AI) system for detection of COVID-19 pneumonia on chest radiographs. Methods An AI system (CAD4COVID-Xray) was trained on 24,678 CXR images including 1,540 used only for validation while training. The test set consisted of a set of continuously acquired CXR images (n=454) obtained in patients suspected for COVID-19 pneumonia between March 4th and April 6th 2020 in a single center (223 RT-PCR positive subjects, 231 RT-PCR negative subjects). The radiographs were independently analyzed by six readers and by the AI system. Diagnostic performance was performed by receiver operating characteristic curve analysis. Results For the test set, the mean age of the patients was 67.3 (+/-14.4) years (56% male). Using RT-PCR test results as the reference standard, the AI system correctly classified CXR images as COVID-19 pneumonia with an AUC of 0.81. The system significantly outperforms each reader (p < 0.001 using McNemar test) at their highest possible sensitivities. At their lowest sensitivities, only one reader can significantly outperform the AI system (p=0.04). Conclusions An AI system for detection of COVID-19 on chest radiographs was comparable to six independent readers.
 

Publication
COVID-19 on the Chest Radiograph: A Multi-Reader Evaluation of an AI System.
Murphy K, Smits H, Knoops AJG, Korst MBJM, Samson T, Scholten ET, Schalekamp S, Schaefer-Prokop CM, Philipsen RHHM, Meijers A, Melendez J, van Ginneken B, Rutten M.
 

 

Related news items


Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

read more

Last chance - Call for nominations Supervisor of the Year & Image award

25 November 2021

The RIMLS PhD Council has extended the deadline to 1 December to nominate supervisors and images for the supervisor of the year and image awards. Send in your nominations while you still can!

read more

The effects of dopamine levels on reward responsivity

25 November 2021

To adapt to the ever-changing context in which we live, we are constantly deciding how much effort to put into performing our behavior, or how fast to perform our actions. How do people decide how fast to act and how does the brain compute this? Our researchers set out to investigate this.

read more

Academic collaboration agreement between UTwente and Radboudumc

23 November 2021

The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc.

read more

New anti-inflammatory drugs increase risk of fungal infection

22 November 2021

Investigators at the Department of Internal Medicine / Infectious Diseases and Dermatology demonstrate worldwide side effects of certain so-called biologics using four different research approaches

read more